{"id":14333,"date":"2026-09-04T12:30:43","date_gmt":"2026-09-04T10:30:43","guid":{"rendered":"https:\/\/bict.it\/s-acetyl-glutathione-efsa-opinion\/"},"modified":"2026-10-25T14:39:47","modified_gmt":"2026-10-25T13:39:47","slug":"s-acetyl-glutathione-efsa-opinion","status":"publish","type":"post","link":"https:\/\/bict.it\/en\/s-acetyl-glutathione-efsa-opinion\/","title":{"rendered":"S-acetyl glutathione: what the EFSA opinion actually says"},"content":{"rendered":"

EFSA has given its safety opinion on S-acetyl glutathione as a novel food. An opinion is not an authorisation, and the months still to run before the implementing act are the best window you will get to decide the product.<\/p>\n

What the opinion says<\/h2>\n

Three numbers a formulation is designed around: adolescents from 10 years and adults<\/strong>, up to 300 mg per day<\/strong>, in food supplements and foods for special medical purposes<\/strong>. The draft opinion was in public consultation between 19 September and 10 October 2025.<\/p>\n

EFSA assesses; it does not authorise. Authorisation comes when the Commission adopts the implementing regulation adding the ingredient to the Union list<\/em>. EFSA has nine months to deliver its opinion once the application is forwarded, the Commission then seven months from the opinion to table the act: legal deadlines, not promises, but they give a horizon. And listing is normally generic \u2014 once authorised, any operator may use the ingredient under the stated conditions, unless the applicant obtained data protection.<\/p>\n

Do not confuse it with reduced glutathione<\/h2>\n

They are different molecules and distinct regulatory objects: what holds for one says nothing about the other. A supplier who uses the two names interchangeably on a technical data sheet is telling you how carefully they read a specification.<\/p>\n

The second active is the real decision<\/h2>\n

In a supplement this ingredient will not work alone. The strongest commercial target today is the antioxidant and healthy-ageing shelf, adults from 35: it is the largest slice of the category and the easiest positioning to defend, because the health claim \u2014 when there is one \u2014 comes from the authorised nutrient beside it.<\/p>\n

That target narrows the shortlist of second actives: vitamin C, vitamin E, L-selenomethionine, zinc<\/strong>. And what decides the product is not whether the single ingredient works, but whether the pairing does more than the sum of its parts, at which ratio and through which mechanism. That question is answered in cells, comparing pairings against each other.<\/p>\n

Check compatibility before you choose<\/h2>\n

Compatibility is not a given, and it often depends on the chemical form rather than the substance.<\/p>\n